Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Donna R. Rivera(National Cancer Institute), Jeremy L. Warner(Vanderbilt University Medical Center), Deborah B. Doroshow(Icahn School of Medicine at Mount Sinai), Jessica E. Hawley(Columbia University Irving Medical Center), Ali Raza Khaki(University of Washington), Dimitrios Farmakiotis(Brown University), Shilpa Gupta(Vels University), Matthew D. Galsky(Icahn School of Medicine at Mount Sinai), Christopher A. Lemmon(Cleveland Clinic), Leslie A. Fecher(University of Pennsylvania), Brian I. Rini(CancerCare Manitoba), Petros Grivas(Fred Hutch Cancer Center), Sanjay Goel(Albert Einstein College of Medicine), Ziad Bakouny(Dana-Farber Cancer Institute), Lidia Schapira(Palo Alto University), Michael A. Thompson(Mayo Clinic), Albert C. Yeh(University of Washington), Julie Wu(Palo Alto University), Chih–Yuan Hsu(Vanderbilt University Medical Center), Nicole M. Kuderer, Dimpy P. Shah(The University of Texas MD Anderson Cancer Center), Zhuoer Xie(Mayo Clinic), Corrie Painter, Toni K. Choueiri(Dana-Farber Cancer Institute), Sanjay G. Revankar, Adam J. Olszewski, Sanjay Mishra(Vanderbilt University Medical Center), Yu Shyr(Vanderbilt University), Solange Peters(University Hospital of Lausanne), Christopher R. Friese(University of Michigan), Gilberto Lopes(University of Miami), Jonathan Arcobello(The Barbara Ann Karmanos Cancer Institute), Gary H. Lyman(University of Washington), Matthew Puc(Virtua Health), Samuel M. Rubinstein(Vanderbilt University Medical Center), Orestis A. Panagiotou(Brown University), Balázs Halmos(University Hospitals of Cleveland), Brendan J. Lee(Vanderbilt University Medical Center), Sumit Shah(Palo Alto University), Andrew Schmidt(Dana-Farber Cancer Institute), Þorvarður R. Hálfdánarson(Mayo Clinic), Pamela Egan(Brown University), Nathan A. Pennell(Cleveland Clinic), Huili Zhu(Jinan University), Gary K. Schwartz(Cornell University)
Cited by 138
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k